Immune Cell Engineering Market Size, Share & Industry Analysis, By Product (Reagents, Consumables & Cell Inputs, Instruments & Systems, and Software & Digital Platforms), By Cell Type (T Cells, Natural Killer Cells, and Macrophages), By Technology (CRISPR-Cas Editing, Base Editing, and Prime Editing), By Delivery (Viral Vector Delivery, Electroporation, and Lipid Nanoparticle Delivery), By Application (Cell Therapy R&D and Cell Therapy Manufacturing), By End User (Biopharma & Cell Therapy Companies, CDMOs & CTDMOs, and Academic & Research Institutes), and Regional Forecast, 2026-2034

Last Updated: October 21, 2026 | Format: PDF | Report ID: FBI119492

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 12.49% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Product, Cell Type, Technology, Delivery, Application, Therapeutic Area, End User, and Region
By Product	Reagents, Consumables & Cell Inputs Instruments & Systems Software & Digital Platforms Others
By Cell Type	T Cells Natural Killer Cells Natural Killer T Cells Macrophages & Monocytes Dendritic Cells B Cells Neutrophils & Other Granulocytes Others
By Technology	CRISPR-Cas Editing Base Editing Prime Editing TALEN Editing ZFN Editing Gene Addition RNA Programming Gene Regulation Others
By Delivery	Viral Vector Delivery Electroporation & Nucleofection Lipid Nanoparticle Delivery Polymeric & Other Nanoparticle Delivery Microfluidic & Mechanical Delivery Others
By Application	Cell Therapy R&D Cell Therapy Manufacturing Drug Discovery & Screening Disease Modeling Basic Immunology Research Diagnostics & Biosensing Others
By Therapeutic Area	Oncology Autoimmune & Inflammatory Diseases Infectious Diseases Transplantation Fibrotic Diseases Genetic & Blood Disorders Regenerative Medicine Others
By End User	Biopharma & Cell Therapy Companies CDMOs & CTDMOs Academic & Research Institutes Hospitals & Medical Centers CROs Others
By Region	North America (By Product, Cell Type, Technology, Delivery, Application, Therapeutic Area, End User, and Country) U.S. Canada Europe (By Product, Cell Type, Technology, Delivery, Application, Therapeutic Area, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Product, Cell Type, Technology, Delivery, Application, Therapeutic Area, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Product, Cell Type, Technology, Delivery, Application, Therapeutic Area, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product, Cell Type, Technology, Delivery, Application, Therapeutic Area, End User, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa